Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackie D Corbin

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Handbook of Experimental Pharmacology|December 18, 2008
Cyclic GMP-hydrolyzing phosphodiesterasesSharron H Francis, Jackie D Corbin, Erwin Bischoff
Physiological Reviews|April 30, 2011
Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functionsSharron H Francis, Mitsi A Blount, Jackie D Corbin
Urology|November 5, 2002
Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunctionJackie D Corbin, Sharron H Francis, David J Webb
The Journal of Biological Chemistry|August 23, 2003
Dimerization of cGMP-dependent protein kinase Ibeta is mediated by an extensive amino-terminal leucine zipper motif, and dimerization modulates enzyme functionRobyn Richie-Jannetta, Sharron H Francis, Jackie D Corbin
The Journal of Pharmacology and Experimental Therapeutics|July 31, 2009
Interactions between cyclic nucleotide phosphodiesterase 11 catalytic site and substrates or tadalafil and role of a critical Gln-869 hydrogen bondJames L Weeks, Jackie D Corbin, Sharron H Francis
Neurochemistry International|August 18, 2004
Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5)Jackie D Corbin, Alfreda Beasley, Mitsi A Blount, et al.
The Journal of Biological Chemistry|January 29, 2005
Structural and functional features in human PDE5A1 regulatory domain that provide for allosteric cGMP binding, dimerization, and regulationRoya Zoraghi, Emmanuel P Bessay, Jackie D Corbin, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005
Molecular properties of mammalian proteins that interact with cGMP: protein kinases, cation channels, phosphodiesterases, and multi-drug anion transportersSharron H Francis, Mitsi A Blount, Roya Zoraghi, et al.
Biochemistry|August 19, 2007
N-Terminal domain of phosphodiesterase-11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is involved in oligomerizationJames L Weeks, Roya Zoraghi, Sharron H Francis, et al.
Pharmacological Reviews|August 19, 2010
cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP actionSharron H Francis, Jennifer L Busch, Jackie D Corbin, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Handbook of Experimental Pharmacology|December 18, 2008
Cyclic GMP-hydrolyzing phosphodiesterasesSharron H Francis, Jackie D Corbin, Erwin Bischoff
Physiological Reviews|April 30, 2011
Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functionsSharron H Francis, Mitsi A Blount, Jackie D Corbin
Urology|November 5, 2002
Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunctionJackie D Corbin, Sharron H Francis, David J Webb
The Journal of Biological Chemistry|August 23, 2003
Dimerization of cGMP-dependent protein kinase Ibeta is mediated by an extensive amino-terminal leucine zipper motif, and dimerization modulates enzyme functionRobyn Richie-Jannetta, Sharron H Francis, Jackie D Corbin
The Journal of Pharmacology and Experimental Therapeutics|July 31, 2009
Interactions between cyclic nucleotide phosphodiesterase 11 catalytic site and substrates or tadalafil and role of a critical Gln-869 hydrogen bondJames L Weeks, Jackie D Corbin, Sharron H Francis
Neurochemistry International|August 18, 2004
Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5)Jackie D Corbin, Alfreda Beasley, Mitsi A Blount, et al.
The Journal of Biological Chemistry|January 29, 2005
Structural and functional features in human PDE5A1 regulatory domain that provide for allosteric cGMP binding, dimerization, and regulationRoya Zoraghi, Emmanuel P Bessay, Jackie D Corbin, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005
Molecular properties of mammalian proteins that interact with cGMP: protein kinases, cation channels, phosphodiesterases, and multi-drug anion transportersSharron H Francis, Mitsi A Blount, Roya Zoraghi, et al.
Biochemistry|August 19, 2007
N-Terminal domain of phosphodiesterase-11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is involved in oligomerizationJames L Weeks, Roya Zoraghi, Sharron H Francis, et al.
Pharmacological Reviews|August 19, 2010
cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP actionSharron H Francis, Jennifer L Busch, Jackie D Corbin, et al.
Pageof 5